Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Deep Learning-Based System Detects and Classifies Mammogram Masses

By HospiMedica International staff writers
Posted on 16 Aug 2018
Researchers from the Kyung Hee University (Yongin, South Korea) have developed a fully integrated computer-aided diagnosis (CAD) system that uses deep learning and a deep convolutional neural network (CNN) to detect, segment and classify masses from mammograms. More...
In a new study published by the International Journal of Medical Informatics, the researchers have described the use of their regional deep learning model, You-Only-Look-Once (YOLO), to detect breast mass from entire mammograms. The researchers then went on to use a new deep network model based on a full resolution convolutional network (FrCN), to segment the mass lesions pixel-to-pixel. Finally, a deep CNN was used to recognize the mass and classify it as either benign or malignant.

The researchers used the publicly available and annotated INbreast database to evaluate the integrated CAD system’s accuracy in detection, segmentation, and classification. According to the researchers, the evaluation results of the proposed CAD system via four-fold cross-validation tests showed a mass detection accuracy of 98.96%, Matthews correlation coefficient (MCC) of 97.62%, and F1-score of 99.24% with the INbreast dataset. The mass segmentation results via FrCN demonstrated an overall accuracy of 92.97%, MCC of 85.93%, and Dice (F1-score) of 92.69% and Jaccard similarity coefficient metrics of 86.37%, respectively. The detected and segmented masses classified via CNN achieved an overall accuracy of 95.64%, AUC of 94.78%, MCC of 89.91%, and F1-score of 96.84%, respectively.

The researchers concluded that that the CAD system outperformed the latest conventional deep learning methodologies and will assist radiologists in all the stages of detection, segmentation, and classification.

Related Links:
Kyung Hee University

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.